Clarivate Plc, a global provider of transformative intelligence, has revealed the agenda for the 15th annual Clarivate Pharmavision India conference. The event underscores the industry's commitment to patient welfare, focusing on how innovative strategies and collective efforts are reshaping the healthcare ecosystem. The two-day conference, centered on improving patient outcomes and building resilience, will be held in Ahmedabad and Hyderabad on September 25-26, 2024.
In a country with over a billion people, addressing healthcare challenges such as affordability and access remains critical. Organizations must implement effective, patient-centric strategies across various functions to ensure a strong return on investment and maintain a competitive edge. As the healthcare landscape continues to evolve, balancing these priorities is essential for sustainable growth and improved patient outcomes. Pharmavision India 2024 will provide a platform for industry professionals to discuss and tackle the most pressing challenges in life sciences and healthcare.
This year’s agenda features valuable insights from industry leaders and analysts, with sessions covering innovative R&D, generics, biosimilars, and healthcare manufacturing. Highlights include:
· Indian Pharma: Generics versus Innovation – Finding the Balance for Success, by Dr. Keyur Parekh, President, Corporate Strategy, Zydus Lifesciences Limited
· The Role of AI and Big Data in Healthcare: Transformative Impacts and Future Prospects, by Mr. Anirban Roy Chowdhury, Senior General Manager, Amneal Pharmaceuticals
· Cell and Gene Therapy: Addressing Key Barriers for Successful Integration into Clinical Practice in the Indian Context, by Dr. Tulip Nuval, Head of Business Excellence, Intas Pharmaceuticals Limited
· Cell and Gene Therapy: Addressing Key Barriers for Successful Integration into Clinical Practice in the Indian Context, by Mr. Rebu Ninan, Head of Commercial & Market Access, Immuneel Therapeutics Private Limited
· Patients and the LMIC Story: How Indian Companies Drive Affordability in the Global Scenario, by Dr. Rahul Kapur, Head – Medical Affairs (EM) and COE, Biocon Biologics Limited
· Creating Value for Patients and Stakeholders, by Mr. Deepak Sapra, Chief Executive Officer, API and Services, Dr. Reddy’s Laboratories
Pharmavision India 2024 will take place on Wednesday, September 25, 2024, at the Hyatt Ahmedabad, and Thursday, September 26, 2024, at the Taj Deccan, Hyderabad. For more information and to register for this premier event, visit the official website.
Join the conversation and stay connected with Clarivate Life Sciences and Healthcare by mentioning #Pharmavision, #PatientCare, and #Biopharma on X and LinkedIn.
Click here to read the original press release.
